|
|
|
Insider
Information: |
14159, L.p. |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,167,526 |
|
Indirect Shares
|
135,452,076 |
|
|
Direct
Value |
$60,409,463 |
|
|
Indirect Value
|
$18,366,370,765 |
|
|
Total
Shares |
136,619,602 |
|
|
Total
Value |
$18,426,780,228 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2014-03-06 |
1,020 |
2014-03-06 |
2,619,123 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-07-19 |
360,231 |
2013-05-23 |
489,039 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-07-26 |
247,063 |
2016-05-17 |
491,774 |
Premium* |
|
Acadia Pharmaceuticals Inc |
ACAD |
Director, 10% Owner |
2013-01-18 |
346,725 |
2016-08-10 |
22,789,815 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2014-12-09 |
107,504 |
2014-12-10 |
24,995,342 |
Premium* |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2013-06-11 |
104,983 |
2013-06-11 |
414,249 |
Premium* |
|
Beigene Ltd |
BGNE |
Director, 10% Owner |
2016-02-08 |
0 |
2016-11-18 |
83,652,734 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
Director |
|
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
135,739 |
|
- |
|
XOMA |
XOMA Corporation |
Director |
|
2012-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
360,231 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-07-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
247,063 |
|
- |
|
ACAD |
Acadia Pharmaceuticals In... |
Director |
|
2013-01-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
346,725 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2013-05-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
323,148 |
|
- |
|
INCY |
Incyte Corp |
Director |
|
2013-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
355,839 |
|
- |
|
INCY |
Incyte Corp |
Director |
|
2013-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,000 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-01-01 |
4 |
A |
$27.24 |
$59,982 |
I/I |
2,202 |
272,461 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2016-01-01 |
4 |
A |
$35.20 |
$119,962 |
I/I |
3,408 |
308,843 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2016-04-01 |
4 |
A |
$25.48 |
$119,858 |
I/I |
4,704 |
309,627 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2015-10-01 |
4 |
A |
$21.34 |
$119,845 |
I/I |
5,616 |
308,275 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-05-16 |
4 |
A |
$0.00 |
$0 |
I/I |
10,500 |
386,872 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-05-15 |
4 |
B |
$34.10 |
$726,356 |
I/I |
21,200 |
383,372 |
2.25 |
- |
|
XOMA |
XOMA Corporation |
Director |
|
2013-05-23 |
4 |
A |
$0.00 |
$0 |
I/I |
25,200 |
489,039 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2013-06-11 |
4 |
OE |
$4.44 |
$133,200 |
I/I |
30,000 |
380,839 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-05-14 |
4 |
OE |
$7.26 |
$217,800 |
I/I |
30,000 |
382,860 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2013-12-13 |
4 |
B |
$39.65 |
$1,733,276 |
I/I |
43,709 |
359,133 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2016-05-17 |
4 |
OE |
$10.73 |
$531,135 |
I/I |
49,500 |
317,877 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
61,014 |
107,504 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2013-12-16 |
4 |
B |
$39.91 |
$3,143,952 |
I/I |
78,759 |
361,052 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-04 |
4 |
B |
$36.04 |
$3,145,161 |
I/I |
87,042 |
397,765 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-13 |
4 |
B |
$39.80 |
$3,533,527 |
I/I |
88,587 |
416,208 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-02 |
4 |
B |
$34.05 |
$3,225,210 |
I/I |
94,617 |
393,233 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-03 |
4 |
B |
$34.38 |
$3,457,722 |
I/I |
100,304 |
395,659 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2013-05-07 |
4 |
B |
$33.40 |
$3,938,140 |
I/I |
117,254 |
363,887 |
2.25 |
- |
|
55 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|